Cerebrospinal Fluid Proteomics in a Patient with Multidrug-Resistant Acinetobacter baumannii Ventriculitis
Author Information
Author(s): Li Mengyao, Liu Dongyu, Bergen Phillip J., Liang Silin, Chen Juan, Kho Zhi Ying, Lu Jing, Sun Huiying, Hong Weiqing, Liu Xiaofen, Hong Chengying, Chen Youlian, Li Wei, You Hongxia, Xu Shunyao, Wang Yu, Gao Huaiji, Lam Chun Hin, Li Jian, Chen Xiaoyin, Liu Xueyan
Primary Institution: The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, China
Hypothesis
The study investigates the interactions among the host, pathogen, and polymyxins after intrathecal/intraventricular administration.
Conclusion
The study provides insights into the immune activation and blood-brain barrier repair following polymyxin administration in a patient with multidrug-resistant A. baumannii ventriculitis.
Supporting Evidence
- The innate immune system and neuroimmunity were highly active within 24 hours of polymyxin B administration.
- Blood-brain barrier impairment worsened at 24 hours but showed signs of repair on Day 7 and Day 26.
- This is the first CSF proteomic study with polymyxins, providing critical mechanistic insights.
Takeaway
This study looked at how a special treatment helped a patient with a serious brain infection caused by a tough germ, showing that the treatment worked well for the immune system and helped repair the brain's protective barrier.
Methodology
Cerebrospinal fluid proteomics was used to analyze host-pathogen-polymyxin interactions in a patient treated with intrathecal and intravenous polymyxin B.
Potential Biases
The patient received multiple antibiotics, which may have influenced the results.
Limitations
The study involved only a single patient, limiting the generalizability of the findings.
Participant Demographics
A 69-year-old female patient with a history of hypertension and trauma-induced paraplegia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website